Saitama, Japan

Shin-ichi Inoue

This inventor holds 1 USPTO granted patent. Top assignee: Taiho Pharmaceutical Company Limited. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shin-ichi Inoue. Retrieved from https://idiyas.com/inventor/shin-ichi-inoue-jackcmn0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shin-ichi Inoue: Innovator in Pharmaceutical Chemistry

Introduction

Shin-ichi Inoue is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds.

Latest Patents

Inoue holds a patent for "Benzimidazole derivatives and pharmacologically acceptable salts thereof." This invention provides a compound that exhibits both IL-4 production inhibitory activity and PDE (IV) inhibitory activity, represented by a specific formula. His work in this area demonstrates a commitment to advancing therapeutic options in medicine.

Career Highlights

Inoue is associated with Taiho Pharmaceutical Company Limited, where he has been instrumental in research and development. His expertise in pharmaceutical chemistry has led to advancements that benefit the medical community and patients alike.

Collaborations

Inoue has collaborated with esteemed colleagues, including Shozo Yamada and Toshiyuki Hosoya. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Shin-ichi Inoue's contributions to pharmaceutical chemistry, particularly through his patented inventions, highlight his role as a key innovator in the industry. His work continues to influence the development of new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…